Erwin A van Vliet Selected Research

L 701324

5/2014

Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erwin A van Vliet Research Topics

Disease

34	Epilepsy (Aura) 10/2021 - 07/2002
29	Seizures (Absence Seizure) 01/2022 - 08/2002
27	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 08/2002
24	Temporal Lobe Epilepsy 01/2022 - 07/2002
11	Inflammation (Inflammations) 10/2021 - 07/2011
8	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 01/2018
4	Focal Cortical Dysplasia 10/2021 - 01/2019
4	Neuroinflammatory Diseases 11/2020 - 03/2014
4	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 07/2011
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 01/2020
3	Hippocampal Sclerosis 10/2021 - 09/2011
3	Epileptic Syndromes 01/2021 - 07/2002
3	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2005
3	Neoplasms (Cancer) 12/2012 - 09/2003
2	Drug Resistant Epilepsy 01/2022 - 09/2003
2	Gliosis 01/2022 - 01/2016
2	Astrocytoma (Pilocytic Astrocytoma) 01/2020 - 06/2018
2	Carcinogenesis 01/2020 - 06/2018
2	Disease Progression 01/2019 - 07/2017
2	Glioma (Gliomas) 06/2018 - 12/2012
2	Ganglioglioma 06/2018 - 09/2003
2	Glioblastoma (Glioblastoma Multiforme) 06/2018 - 12/2012
2	Brain Diseases (Brain Disorder) 12/2017 - 02/2014
2	Central Nervous System Diseases (CNS Diseases) 05/2014 - 09/2009
1	Intellectual Disability (Idiocy) 01/2022
1	Autism Spectrum Disorder 01/2022
1	Neurodevelopmental Disorders 10/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Cognitive Dysfunction 01/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Sudden Unexpected Death in Epilepsy 01/2021
1	Depressive Disorder (Melancholia) 01/2020
1	Hamartoma 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Malformations of Cortical Development 01/2020
1	Hemimegalencephaly 01/2019
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2018
1	Body Weight (Weight, Body) 01/2016

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
11	Pharmaceutical PreparationsIBA 01/2022 - 12/2004
7	Kainic Acid (Kainate)IBA 01/2021 - 06/2003
6	trans-sodium crocetinate (crocetin)IBA 01/2022 - 01/2019
6	TOR Serine-Threonine KinasesIBA 10/2021 - 07/2012
6	Sirolimus (Rapamycin)FDA Link 01/2019 - 07/2012
5	Messenger RNA (mRNA)IBA 01/2021 - 06/2003
5	Biomarkers (Surrogate Marker)IBA 04/2020 - 04/2013
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 07/2008
5	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2014
3	AntioxidantsIBA 01/2022 - 01/2019
3	CurcuminIBA 01/2022 - 01/2016
3	IronIBA 10/2021 - 09/2005
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 07/2018
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 02/2010
3	CytokinesIBA 07/2018 - 12/2012
3	Sodium Channels (Sodium Channel)IBA 09/2013 - 07/2002
3	Levetiracetam (Keppra)FDA LinkGeneric 03/2010 - 07/2008
3	Phenytoin (Dilantin)FDA LinkGeneric 02/2010 - 04/2006
2	Matrix Metalloproteinase InhibitorsIBA 01/2021 - 07/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2006
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 06/2005
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 06/2005
2	Drug CombinationsIBA 01/2019 - 07/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2013
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2015 - 05/2014
2	InterleukinsIBA 10/2015 - 04/2013
2	Phenobarbital (Luminal)FDA Link 05/2014 - 06/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2010 - 02/2010
2	major vault proteinIBA 12/2004 - 09/2003
1	Cell Adhesion MoleculesIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	ProteomeIBA 01/2021
1	AlbuminsIBA 11/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	ChloridesIBA 11/2018
1	BenzodiazepinesIBA 11/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2018
1	gamma-Aminobutyric Acid (GABA)IBA 11/2018
1	Flunitrazepam (Rohypnol)IBA 11/2018
1	protectin D1IBA 11/2018
1	CannabidiolIBA 11/2018
1	docosapentaenoic acidIBA 11/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	gadobutrolIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Contrast MediaIBA 01/2016
1	Glycine Plasma Membrane Transport ProteinsIBA 12/2015
1	LY2365109IBA 12/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2015
1	Phosphotransferases (Kinase)IBA 10/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2015
1	L 701324IBA 05/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2014
1	GlucocorticoidsIBA 03/2014

Therapy/Procedure

9	Therapeutics 10/2021 - 02/2014
1	Aftercare (After-Treatment) 11/2018